Kelt - Cellceutix is the sponsor of this phase one trial. DF sponsored preclinical combo trial with aromatase inhibitor. U Bolog sponsoring ano trial. This one - with humans and quite expensive - belongs to ctix. See how Leo differentiates the sponsor in his recent pr? "Company-sponsored clinical trials at Harvard University’s Dana-Farber Cancer Center and partner Beth Israel Deaconess Medical Center began in November testing Kevetrin for safety against solid tumors."  This has always been ctix's baby - not DF's. They are the hired and contracted research organization only for this trial.